Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
Medpace Holdings (MEDP) Stock Price & Analysis
471 Followers
MEDP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$207.47 - $421.00
Previous Close$386.34
Volume292.76K
Average Volume (3M)225.61K
Market Cap
$11.97B
Enterprise Value$12.13B
Total Cash (Recent Filing)$39.14M
Total Debt (Recent Filing)$194.39M
Price to Earnings (P/E)39.4
Beta1.64
Next Earnings
Jul 22, 2024EPS Estimate
$2.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.81
Shares Outstanding30,983,399
10 Day Avg. Volume158,426
30 Day Avg. Volume225,606
Standard Deviation0.12
R-Squared0.37
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-38.83
Price to Sales (P/S)8.20
Price to Cash Flow (P/CF)36.30
P/FCF Ratio40.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.25
Enterprise Value/Gross Profit28.04
Enterprise Value/Ebitda36.00
Forecast
1Y Price Target
$447.14Price Target Upside15.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Medpace Holdings News
Bulls Say, Bears Say
Bulls Say
Financial HealthMEDP maintains a healthy balance sheet with no debt, providing financial flexibility and resilience in uncertain interest rate environments.
Financial PerformanceMEDP continues to outperform the biotech trend with substantial revenue, EBITDA, and EPS growth.
Market PositionMedpace has nearly doubled its market share from 2016 to 2023 and industry feedback has been increasingly constructive over the last 18 months.
Bears Say
Financial PerformanceNet bookings did miss by ~$13M, or -0.03x on B2B.
Future Revenue ConcernsBookings for Medpace could have been better, as the net book-to-bill ratio was slightly below the recent average and expectations, indicating potential softness in future revenue.
Market ValuationThe primary reservation is valuation, with the stock trading at 31x 2025 EPS versus peers at 21x.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
MEDP FAQ
What was Medpace Holdings’s price range in the past 12 months?
Medpace Holdings lowest stock price was $207.47 and its highest was $421.00 in the past 12 months.
What is Medpace Holdings’s market cap?
Currently, no data Available
When is Medpace Holdings’s upcoming earnings report date?
Medpace Holdings’s upcoming earnings report date is Jul 22, 2024 which is in 49 days.
How were Medpace Holdings’s earnings last quarter?
Medpace Holdings released its earnings results on Apr 22, 2024. The company reported $3.2 earnings per share for the quarter, beating the consensus estimate of $2.466 by $0.734.
Is Medpace Holdings overvalued?
According to Wall Street analysts Medpace Holdings’s price is currently Undervalued.
Does Medpace Holdings pay dividends?
Medpace Holdings does not currently pay dividends.
What is Medpace Holdings’s EPS estimate?
Medpace Holdings’s EPS estimate is $2.53.
How many shares outstanding does Medpace Holdings have?
Medpace Holdings has 30,983,398 shares outstanding.
What happened to Medpace Holdings’s price movement after its last earnings report?
Medpace Holdings reported an EPS of $3.2 in its last earnings report, beating expectations of $2.466. Following the earnings report the stock price went up 8.21%.
Which hedge fund is a major shareholder of Medpace Holdings?
Among the largest hedge funds holding Medpace Holdings’s share is Fisher Asset Management LLC. It holds Medpace Holdings’s shares valued at 48M.
---
Medpace Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$447.14 (15.74% Upside)
$447.14 (15.74% Upside)
Blogger Sentiment
Bullish
MEDP Sentiment 85%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 36.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $386.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.8%
Last 30 Days ▲ 7.4%
Last 30 Days ▲ 7.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
86.66%
12-Months-Change
Fundamentals
Return on Equity
61.31%
Trailing 12-Months
Asset Growth
28.66%
Trailing 12-Months
Company Description
Medpace Holdings
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
---
MEDP Company Deck
---
MEDP Earnings Call
Q1 2024
0:00 / 0:00
---
MEDP Revenue Breakdown
31.13% Oncology
19.98% Metabolic
10.27% Cardiology
8.66% AVAI
29.95% Other
---
MEDP Stock 12 Month Forecast
Average Price Target
$447.14
▲(15.74% Upside)
Technical Analysis
Best Analysts Covering MEDP
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
+13.58%
upgraded a buy rating last month
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +13.58% per trade.
---